Viewing nowCombinationAblatane A Plus 5/160/20 mg Tablet
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202006657 · Approved 2020.09.25 · Insurance code 657308410
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease (including myocardial infarction)
This medication is used for patients with essential hypertension who do not achieve sufficient blood pressure control with monotherapy of amlodipine/valsartan combination therapy. Atorvastatin also plays a role in reducing the risk of cardiovascular diseases. It is particularly beneficial in reducing cardiovascular risks such as myocardial infarction, stroke, vascular interventions, and angina in adults with multiple risk factors for coronary heart disease or in patients with type 2 diabetes. Furthermore, it helps improve vascular health by managing cholesterol and triglyceride levels in patients with dyslipidemia. This combination therapy effectively controls blood pressure and lipid levels, thereby reducing the risk of cardiovascular diseases.
Take 1 tablet once daily with water. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. For patients taking the amlodipine/valsartan combination and atorvastatin as separate medicines concomitantly, they may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg as monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg as monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg as monotherapy, or with 5/160 mg. - Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. The amlodipine/valsartan combination should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring greater reductions in LDL-cholesterol levels may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL-cholesterol reduction of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL-cholesterol levels, it is recommended that LDL-cholesterol levels be used when initiating treatment and evaluating the response. However, if LDL-cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. - Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dose adjustment is necessary. - Elderly patients: Efficacy and safety in elderly patients aged 70 years or older are generally similar to those in the general adult patient population.
This medication can cause serious harm to the fetus and newborn when taken during pregnancy, especially in the second and third trimester, so it must be discontinued immediately upon confirmation of pregnancy. Discontinue use if there are symptoms related to muscles or if muscle enzyme levels increase significantly, and patients at risk of severe myopathy should be monitored more closely. Patients with allergic reactions to any of the components, certain liver or kidney diseases, and women who are pregnant or breastfeeding should not take this medication. Patients with low sodium or fluid levels in the body may experience hypotension, so it is important to assess their condition before taking the medication, and blood pressure should be closely monitored during use. Patients with high potassium levels or those taking potassium supplements may experience further increases in potassium levels and regular blood tests are necessary. Patients with renal artery stenosis or those who have recently undergone kidney transplantation should consult their healthcare provider before taking this medication, and should discontinue it immediately if symptoms of angioedema occur. For patients with heart failure or after myocardial infarction, kidney function and blood pressure should be carefully monitored when taking this medication. This medication is not recommended for patients with severely impaired liver function, and it is important to inform the healthcare provider immediately if symptoms of liver dysfunction occur. Caution is advised for patients experiencing dizziness or fatigue while driving or operating machinery. This medication can interact with various drugs, so patients taking other medications should inform their healthcare provider, especially with certain antibiotics, antifungals, and immunosuppressants. Women who are pregnant or planning to become pregnant should not use this medication, and women of childbearing potential should use appropriate contraception. Breastfeeding women are advised to avoid taking this medication, and if atorvastatin is included, breastfeeding should be discontinued. If any abnormal symptoms or discomfort occur during the use of this medication, consult a healthcare provider immediately.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to keep it at room temperature between 1 to 30 degrees Celsius. This helps maintain the effectiveness of the medication over time and ensures its safe use.
Light pink, oval-shaped film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Dong Gu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.